"It is our pleasure to welcome you to the 11th annual Summit on the MDRP. As in prior years, we are delighted to offer you new, in-depth pre-summit educational symposia, highly anticipated keynote presentations and four concurrent tracks for customized learning opportunities. This year we are extremely proud to bring you comprehensive coverage of the two pieces of federal legislation making the biggest impact on the rebate arena—the continued implementation efforts around Medicare Part D and the impacts of the Deficit Reduction Act (DRA).
The latter, signed into law by President Bush in February 2006, is designed to slow the pace of spending growth in both Medicare and Medicaid. Although the passing of the Medicare Modernization Act in 2004 represented the most fundamental and structural change our healthcare system has ever experienced, the DRA signifies the biggest computational changes to the Medicaid Drug Rebate Program since its inception. Together, the MMA drug provisions and the DRA’s implications on manufacturers, states, pharmacies and more continue to bring unprecedented change and uncertainty to an industry striving to maximize beneficiary care, control costs at the state level and ensure compliance.
Carefully structured over three days, the program explores best practices in managing the complex set of rebate responsibilities and avoiding disputes, while maintaining compliance with state and federal regulations. We invite you to review our agenda for 2006. With a comprehensive program, broad topic choices, and an outstanding speaking faculty that give you access to key pharmaceutical manufacturers, states, law firms, consulting firms, government agencies, legislative and policy groups, and enforcement offices, we aim to surpass your expectations for solutions to handling day-to-day rebate processes and ensuring a streamlined, compliant rebate process."